| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AAV and hepatitis: Cause or coincidence?
|
de Jong, Ype P.
|
|
|
30 |
9 |
p. 2875-2876
|
article
|
| 2 |
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
|
McCafferty, Sean
|
|
|
30 |
9 |
p. 2968-2983
|
article
|
| 3 |
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
|
Vesin, Benjamin
|
|
|
30 |
9 |
p. 2984-2997
|
article
|
| 4 |
A precise and efficient adenine base editor
|
Tu, Tianxiang
|
|
|
30 |
9 |
p. 2933-2941
|
article
|
| 5 |
Assessing the state of Medicaid coverage for gene and cell therapies
|
Berry, Diane
|
|
|
30 |
9 |
p. 2879-2880
|
article
|
| 6 |
A truncated reverse transcriptase enhances prime editing by split AAV vectors
|
Gao, Zongliang
|
|
|
30 |
9 |
p. 2942-2951
|
article
|
| 7 |
Broadening prime editing toolkits using RNA-Pol-II-driven engineered pegRNA
|
Huang, Shisheng
|
|
|
30 |
9 |
p. 2923-2932
|
article
|
| 8 |
Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques
|
Zabaleta, Nerea
|
|
|
30 |
9 |
p. 2952-2967
|
article
|
| 9 |
Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes
|
Cheng, Qinqin
|
|
|
30 |
9 |
p. 3066-3077
|
article
|
| 10 |
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen
|
Taha, Zaid
|
|
|
30 |
9 |
p. 2998-3016
|
article
|
| 11 |
In this issue
|
|
|
|
30 |
9 |
p. 2877-2878
|
article
|
| 12 |
Knockdown of MicroRNA Let-7a Improves the Functionality of Bone Marrow-Derived Mesenchymal Stem Cells in Immunotherapy
|
Yu, Yang
|
|
|
30 |
9 |
p. 3095
|
article
|
| 13 |
Lipid nanoparticle-mediated silencing of osteogenic suppressor GNAS leads to osteogenic differentiation of mesenchymal stem cells in vivo
|
Basha, Genc
|
|
|
30 |
9 |
p. 3034-3051
|
article
|
| 14 |
Macrophages as a therapeutic target to promote diabetic wound healing
|
Sharifiaghdam, Maryam
|
|
|
30 |
9 |
p. 2891-2908
|
article
|
| 15 |
mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells
|
Bevers, Sanne
|
|
|
30 |
9 |
p. 3078-3094
|
article
|
| 16 |
P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition
|
Chen, Junzhe
|
|
|
30 |
9 |
p. 3017-3033
|
article
|
| 17 |
Targeting glycans for CAR therapy: The advent of sweet CARs
|
Raglow, Zoe
|
|
|
30 |
9 |
p. 2881-2890
|
article
|
| 18 |
Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo
|
Gorsuch, Cassandra L.
|
|
|
30 |
9 |
p. 2909-2922
|
article
|
| 19 |
Tumor necrosis factor alpha delivers exogenous inflammation-related microRNAs to recipient cells with functional targeting capabilities
|
Zhao, Yuechao
|
|
|
30 |
9 |
p. 3052-3065
|
article
|
Journal description